BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
158 hedge funds and large institutions have $309M invested in BioDelivery Sciences International, Inc. in 2020 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 59 increasing their positions, 40 reducing their positions, and 19 closing their positions.
104% more call options, than puts
Call options by funds: $485K | Put options by funds: $238K
48% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 40
37% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 19
18% more capital invested
Capital invested by funds: $263M → $309M (+$46.4M)
3% more funds holding
Funds holding: 153 → 158 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.72M |
| 2 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$3.21M |
| 3 |
BlackRock
New York
|
+$3.08M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$2.5M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$2.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$6.21M |
| 2 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
-$6.04M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
-$4.34M |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$2.86M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$1.52M |
BDSI Hedge Fund Activity: Q2 2020 in Review
158 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q2 2020, worth a combined $309M — up 18% from $263M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new BDSI positions and 19 closed out — a net gain of 7 holders — while 59 added to existing stakes and 40 trimmed.
The largest buyer was Vanguard Group, adding an estimated $3.72M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $6.21M sold.
- 158 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q2 2020, up from 153 in Q1 2020.
- Funds reported $309M of BioDelivery Sciences International, Inc. stock for Q2 2020, up 18% quarter-over-quarter.
- 26 funds opened new BioDelivery Sciences International, Inc. positions in Q2 2020 and 19 closed out, a net change of +7 holders.
- The largest BioDelivery Sciences International, Inc. buyer in Q2 2020 was Vanguard Group, an estimated $3.72M added.
- The largest BioDelivery Sciences International, Inc. seller in Q2 2020 was Baker Bros. Advisors, an estimated $6.21M sold.
Based on aggregated 13F filings for Q2 2020.